138 related articles for article (PubMed ID: 7039256)
1. Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.
Cory JG; Sato A; Lasater L
Adv Enzyme Regul; 1980; 19():139-50. PubMed ID: 7039256
[No Abstract] [Full Text] [Related]
2. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Sato A; Bacon PE; Cory JG
Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).
Moore EC; Hurlbert RB
Pharmacol Ther; 1985; 27(2):167-96. PubMed ID: 3898152
[No Abstract] [Full Text] [Related]
4. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Sato A; Cory JG
Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
[TBL] [Abstract][Full Text] [Related]
5. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.
Cory JG; Lasater L; Sato A
Biochem Pharmacol; 1981 May; 30(9):979-84. PubMed ID: 6786297
[No Abstract] [Full Text] [Related]
6. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
[TBL] [Abstract][Full Text] [Related]
7. Uridine diphosphate reductase of Ehrlich ascites tumor is insensitive to hydroxyurea.
Murayama J; Morita T; Fukui N; Moriyama Y; Fujimura S
Biochem Biophys Res Commun; 1985 Feb; 126(3):1104-8. PubMed ID: 3884001
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
Carter GL; Thompson DP; Cory JG
Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
[TBL] [Abstract][Full Text] [Related]
9. Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
Gale GR; Atkins LM; Meischen SJ; Schwartz P
Cancer Treat Rep; 1979 Mar; 63(3):449-56. PubMed ID: 427825
[TBL] [Abstract][Full Text] [Related]
10. Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.
Yu Y; Kalinowski DS; Kovacevic Z; Siafakas AR; Jansson PJ; Stefani C; Lovejoy DB; Sharpe PC; Bernhardt PV; Richardson DR
J Med Chem; 2009 Sep; 52(17):5271-94. PubMed ID: 19601577
[No Abstract] [Full Text] [Related]
11. A quantitative analysis of steric and hydrophobic effects in ribonucleoside diphosphate reductase inhibition by thiosemicarbazones.
Gupta SP; Prabhakar YS; Bindal MC; Handa A
Arzneimittelforschung; 1984; 34(2):147-50. PubMed ID: 6372802
[TBL] [Abstract][Full Text] [Related]
12. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
[No Abstract] [Full Text] [Related]
13. Quenching of tyrosine radicals of M2 subunit from ribonucleotide reductase in tumor cells by different antitumor agents: an EPR study.
Liermann B; Lassmann G; Langen P
Free Radic Biol Med; 1990; 9(1):1-4. PubMed ID: 2170241
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nucleoside diphosphate reductase by hydroxybenzohydroxamic acid derivatives.
Elford HL; van't Riet B
Pharmacol Ther; 1985; 29(2):239-54. PubMed ID: 3939037
[No Abstract] [Full Text] [Related]
15. Inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Moore EC; Sartorelli AC
Pharmacol Ther; 1984; 24(3):439-47. PubMed ID: 6379688
[No Abstract] [Full Text] [Related]
16. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
17. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
Booth BA; Agrawal KC; Moore EC; Sartorelli AC
Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
[No Abstract] [Full Text] [Related]
18. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
Lewis WH; Wright JA
J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
[TBL] [Abstract][Full Text] [Related]
19. A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity.
Hards RG; Wright JA
Can J Biochem Cell Biol; 1983; 61(2-3):120-9. PubMed ID: 6342725
[TBL] [Abstract][Full Text] [Related]
20. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents.
Elford HL; Van't Riet B; Wampler GL; Lin AL; Elford RM
Adv Enzyme Regul; 1980; 19():151-68. PubMed ID: 6175187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
